Skip to main content

Table 3 Univariate analysis of DFS and OS according to clinicopathological variables

From: Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases

Variables

DFS

OS

χ 2

P-value

χ 2

P-value

Age (years)

≤50 vs. >50

0.058

0.810

0.436

0.509

Tumor size (cm)a

≤2 vs. >2, ≤5 vs. >5

2.515

0.284

2.608

0.271

Lymph node stage

negative vs. positive

11.706

0.001

8.803

0.003

Grade

G1 vs. G2 vs. G3

4.764

0.092

3.204

0.201

Clinical stagea

I vs. II vs. III and IV

10.343

0.006

8.576

0.014

Histological type

IDC vs. ILC vs. Others

0.588

0.745

0.883

0.643

Ki-67 LI

Low (≤14 %) vs. High (>14 %)

1.974

0.160

2.709

0.100

Chemotherapy

AC vs. AC-T vs. Others vs. None

0.664

0.882

1.194

0.754

Radiotherapy

No vs. Yes

0.091

0.763

0.002

0.963

PELP1 status

Low vs. High

2.887

0.089

3.182

0.074

  1. Abbreviations: LN, lymph node; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; Ki-67 LI, Ki-67 label index; AC, Adriamycin/Cyclophosphamide; AC-T, Adriamycin/Cyclophosphamide-Taxol; DFS, disease-free survival; OS, overall survival
  2. Note: afor the variable, data for two cases are unavailable from medical records
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us